Market Overview

OPKO Health Receives U.S. Patent Allowance

OPKO Health, Inc. (NYSE: OPK) today announced the receipt of a patent allowance from the U.S. Patent and Trademark Office (USPTO) for the patent application titled “Flow Control in Microfluidic Systems”.

Posted in: News, FDA

 

Around the Web, We're Loving...

Most Popular

Related Articles (OPK)

Partner Network

Get Benzinga's News Delivered Free

Benzinga Professional